Chordoma is a rare tumor that occurs along the axial spine in pediatrics and adults, with an
incidence of approximately 350 cases per year in the United States. While typically …

Simple Summary Surgery is the primary treatment for chordoma. However, residual or
recurrent chordoma presents a significant problem for clinicians. The aim of this work is to …

Chordomas are rare malignant tumors that originate from the notochord remnants and occur
in the skull base, spine and sacrum. Due to a very limited understanding of the molecular …

Chordomas are rare, locally aggressive skull base neoplasms known for local recurrence
and not-infrequent treatment failure. Current evidence supports the role of maximal safe …

Chordomas are rare primary malignant tumors of the bones that occur along the skull base,
spine, and sacrum. Long-term survival and neurological outcome continue to be challenging …

Chordomas are one of the rarest bone tumors, and they originate from remnants of
embryonic notochord along the spine, more frequently at the skull base and sacrum …

Aim: To investigate the expression of platelet-derived growth factor (PDGF) receptor-A
(PDGFRα), epidermal growth factor receptor (EGFR) and c-Met in spinal chordoma. To the …

Background Chordomas are very rare low-grade malignant bone tumors that arise from the
embryonic rests of the notochord. They are characterized by slow growth and long history …

Chordomas are rare primary bone tumors that occur along the neuraxis. Primary treatment is
surgery, often followed by radiotherapy. Treatment options for patients with recurrence are …

Chordoma is a malignant tumor thought to arise from remnants of the embryonic notochord,
with its origin in the bones of the axial skeleton. Surgical resection is the standard treatment …